La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Aqua Bio Technology Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Havard Lindstrom

Amministratore delegato

NOK 1.4m

Compenso totale

Percentuale dello stipendio del CEO	94.4%
Mandato del CEO	3.1yrs
Proprietà del CEO	0.7%
Durata media del management	Nessun dato
Durata media del Consiglio di amministrazione	2.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Jan 20

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Dec 30

AMMINISTRATORE DELEGATO

Havard Lindstrom (55 yo)

3.1yrs

Mandato

NOK 1,447,000

Compensazione

Mr. Havard Lindstrom serves as Chief Executive Officer of Aqua Bio Technology ASA since July 2021. He served as the Chairman of Black Sea Property AS since June 2015 until March 3, 2017. Mr. Lindstrom has...

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Roger Hofseth	Director	5.6yrs	NOK 145.00k	Nessun dato
Camilla Andersson	Director	2.2yrs	NOK 145.00k	Nessun dato
Jan Hakan Pettersson	Director	9.2yrs	NOK 145.00k	Nessun dato
Birgit Liodden	Drector	2.2yrs	NOK 145.00k	Nessun dato
Jon Ødegård	Chairman	8.5yrs	NOK 285.00k	Nessun dato
David Huggins	Director	less than a year	Nessun dato	Nessun dato
Gun Lyseng	Director	less than a year	Nessun dato	Nessun dato
Lena Varming	Director	less than a year	Nessun dato	Nessun dato

2.2yrs

Durata media

51yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di ABTEC non è considerato esperto (durata media del mandato 2.2 anni), il che suggerisce un nuovo consiglio.

Aqua Bio Technology Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Aqua Bio Technology ASA, Annual General Meeting, Apr 28, 2023

No independent directors

No independent directors

Chief Executive Officer recently bought kr55k worth of stock

Insider recently sold kr1.9m worth of stock

Director recently bought kr57m worth of stock

Recent updates

New major risk - Financial data availability

New major risk - Share price stability

Aqua Bio Technology ASA to Report Q4, 2024 Results on Feb 12, 2025

New minor risk - Financial data availability

Aqua Bio Technology ASA has filed a Follow-on Equity Offering in the amount of NOK 5 million.

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 12.457015 million.

Aqua Bio Technology ASA (OB:ABTEC) entered into a share purchase agreement to acquire Cover Brands As from Medvind Holding As for NOK 16.5 million.

New major risk - Shareholder dilution

Aqua Bio Technology Asa Receives European Patent for Use of Chaga in Cosmetic Formulations

New minor risk - Shareholder dilution

Aqua Bio Technology ASA announced that it has received NOK 75.999999 million in funding

New major risk - Share price stability

Aqua Bio Technology ASA announced that it expects to receive NOK 76 million in funding

Aqua Bio Technology ASA (OB:ABTEC) entered into a binding agreement in principle to acquire SkinTeam Norge AS for NOK 45 million.

Aqua Bio Technology ASA Provides Earnings Guidance for the Full Year 2023

Aqua Bio Technology ASA, Annual General Meeting, Apr 28, 2023

No independent directors

Aqua Bio Technology ASA (OB:ABT) acquired Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

No independent directors

Aqua Bio Technology ASA Announces Hydrafacial Launches Products Containing Aquabeautine XL in the UK

Chief Executive Officer recently bought kr55k worth of stock

Insider recently sold kr1.9m worth of stock

Director recently bought kr57m worth of stock

Aqua Bio Technology ASA Announces Strategic Partnership with DCP Dermoscience

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Moana Active Skincare Limited for New Zealand and Australia

Aqua Bio Technology ASA Signs an Distribution Agreement with Galaxa Pharma Aps

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Cosmed Beauty AS

Aqua Bio Technology ASA to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr9.20

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Director recently bought kr141k worth of stock

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies of 6 Products from the Product Series Balance & Vitality

Aqua Bio Technology Asa: Hydrafacial Has Entered into Partnership with Restorsea - Conversion Lab Launches Veritas Md Platform

Aqua Bio Technology ASA (OB:ABT) completed the acquisition of distribution of Moana Skincare from Limited Liability Company Management Company AB GROUP.

Aqua Bio Technology ASA Expects to Enter into Three-Year Agreement for the Distribution of Moana Products in New Zealand and Australia

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies by Nordic Beauty

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 2.526 million.

New 90-day high - kr8.35

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Membri del Consiglio di amministrazione

Durata media

Età media